| scholarly article | Q13442814 |
| P2093 | author name string | Hyun Jin Kim | |
| So Yeon Park | |||
| Dong Wook Kwak | |||
| Hyun Mee Ryu | |||
| Ji Hyae Lim | |||
| Shin Young Kim | |||
| P2860 | cites work | The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments | Q28236560 |
| DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia | Q34329498 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Disease specific characteristics of fetal epigenetic markers for non-invasive prenatal testing of trisomy 21 | Q35084533 | ||
| Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction | Q35426799 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Genetics of preeclampsia: paradigm shifts | Q36616005 | ||
| Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia | Q37187628 | ||
| Diagnosis and management of atypical preeclampsia-eclampsia | Q37329571 | ||
| Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester | Q38200952 | ||
| Rapid quantification of DNA methylation by measuring relative peak heights in direct bisulfite-PCR sequencing traces | Q39763241 | ||
| Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension | Q39855290 | ||
| Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction--a pilot study | Q40588231 | ||
| Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. | Q44462391 | ||
| Quad screen as a predictor of adverse pregnancy outcome | Q46628047 | ||
| Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications | Q46651453 | ||
| Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. | Q47889241 | ||
| DNA methylome profiling of maternal peripheral blood and placentas reveal potential fetal DNA markers for non-invasive prenatal testing. | Q50650841 | ||
| Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma. | Q51676158 | ||
| Differential placental gene expression in severe preeclampsia. | Q51794890 | ||
| The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). | Q53314217 | ||
| Non-invasive prenatal determination of fetal gender using QF-PCR analysis of cell-free fetal DNA in maternal plasma. | Q53393750 | ||
| Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis. | Q53597278 | ||
| RASSF1A in maternal plasma as a molecular marker of preeclampsia. | Q54266875 | ||
| Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. | Q54459706 | ||
| Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. | Q54574187 | ||
| Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. | Q54703442 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction | Q58623928 | ||
| Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia | Q58825399 | ||
| Types of Maternal Hypertensive Disease and Their Association with Pathologic Lesions and Clinical Factors | Q59662891 | ||
| First-trimester maternal plasma cell-free fetal DNA and preeclampsia | Q61826541 | ||
| Maternal Plasma Cell-Free Fetal and Maternal DNA at 11-13 Weeks' Gestation: Relation to Fetal and Maternal Characteristics and Pregnancy Outcomes | Q61847818 | ||
| Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia | Q73371440 | ||
| Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia | Q78016981 | ||
| Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy | Q81041229 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 29875-29888 | |
| P577 | publication date | 2015-12-15 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Quantification and Application of Potential Epigenetic Markers in Maternal Plasma of Pregnancies with Hypertensive Disorders | |
| P478 | volume | 16 |
Search more.